|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Straight line rent adjustment | |||||
| Intangible amortization in rental revenue, net | |||||
| Loss on extinguishment of debt | |||||
| Amortization of debt related costs | |||||
| Gain on financing transaction | |||||
| Appreciation (depreciation) of warrants | |||||
| Stock based compensation | |||||
| Gain on sale of real estate | |||||
| Unrealized loss from interest rate swap | |||||
| Loss on interest rate swap | |||||
| Loss in investment of unconsolidated joint ventures | |||||
| Changes in operating assets and liabilities: | |||||
| Other assets | |||||
| Deferred leasing costs | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Acquisition of real estate properties | |||||
| Real estate improvements | |||||
| Proceeds from sale of real estate, net | |||||
| Contribution to and investment in Joint Venture | |||||
| Net investment in sales-type lease | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| (Payment) Proceeds from issuance of common stock, net | |||||
| Repayment of secured debt | |||||
| Proceeds from issuance of unsecured debt | |||||
| Proceeds from line of credit facility | |||||
| Repayment of line of credit facility | |||||
| Repurchase of Series A Preferred Stock | |||||
| Redemption of Series A Preferred Stock | |||||
| Redemption of Series B Preferred Stock | |||||
| Proceeds from financing transaction | |||||
| Financing transaction issuance costs | |||||
| Debt issuance costs | |||||
| Dividends and distributions paid | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash, cash held in escrow, and restricted cash | |||||
| Cash, cash held in escrow, and restricted cash at beginning of period | |||||
| Cash, cash held in escrow, and restricted cash at end of period | |||||
| Supplemental Cash Flow Disclosures: | |||||
| Cash paid for interest | |||||
| Assumption of cash, cash held in escrow, and restricted cash upon consolidation of investment in joint venture | |||||
| Contribution of cash, cash held in escrow and restricted cash investment to Joint Venture | |||||
| Supplemental Non-cash Financing and Investing Activities: | |||||
| Dividends declared included in dividends payable | |||||
| Distribution payable to non-controlling interest holder | |||||
| Contribution of real estate properties to Joint Venture | |||||
| Assumption of secured debt by Joint Venture | |||||
| Assumption of accounts payables, accrued expenses and other liabilities by Joint Venture | |||||
| Contribution of other assets to Joint Venture | |||||
| Financing transaction costs included in accounts payable, accrued expenses and other liabilities | |||||
| Contribution to and investment in joint venture in accounts payable, accrued expenses and other liabilities | |||||
| Real estate improvements included in accounts payable, accrued expenses and other liabilities | |||||
| Deferred leasing costs included in accounts payable, accrued expenses and other liabilities | |||||
| Conversion of common stock warrants | |||||
| Series B accretion to redemption value | |||||
| Conversion of Series B Preferred Stock | |||||
| Consolidation of net book value of investment in joint venture | |||||
| Assumption of other assets upon consolidation of investment in joint venture | |||||
| Assumption of accounts payable, accrued expenses and other liabilities upon consolidation of investment in joint venture | |||||
| Assumption of secured debt upon consolidation of investment in joint venture | |||||
Loading...